Oliver Luxxe Assets’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.03M | Buy |
13,137
+587
| +5% | +$225K | 0.9% | 46 |
|
|
2025
Q1 | $4.34M | Sell |
12,550
-11,674
| -48% | -$4.03M | 0.81% | 48 |
|
|
2024
Q4 | $8.54M | Buy |
24,224
+12,284
| +103% | +$4.33M | 0.76% | 48 |
|
|
2024
Q3 | $4.85M | Buy |
+11,940
| New | +$4.85M | 0.87% | 43 |
|
|
2023
Q4 | – | Sell |
-20,660
| Closed | -$5.08M | – | 172 |
|
|
2023
Q3 | $5.08M | Buy |
20,660
+299
| +1% | +$73.5K | 1.3% | 23 |
|
|
2023
Q2 | $6.18M | Buy |
+20,361
| New | +$6.18M | 1.54% | 11 |
|
|
2022
Q3 | – | Sell |
-14,354
| Closed | -$2.41M | – | 182 |
|
|
2022
Q2 | $2.41M | Buy |
14,354
+1,164
| +9% | +$196K | 0.71% | 51 |
|
|
2022
Q1 | $3.31M | Sell |
13,190
-280
| -2% | -$70.2K | 0.84% | 46 |
|
|
2021
Q4 | $3.46M | Buy |
13,470
+51
| +0.4% | +$13.1K | 0.88% | 37 |
|
|
2021
Q3 | $3.26M | Buy |
13,419
+319
| +2% | +$77.4K | 0.9% | 35 |
|
|
2021
Q2 | $2.71M | Sell |
13,100
-7,662
| -37% | -$1.58M | 0.74% | 45 |
|
|
2021
Q1 | $3.91M | Buy |
+20,762
| New | +$3.91M | 1.17% | 22 |
|
|
2020
Q2 | – | Sell |
-19,703
| Closed | -$2.13M | – | 120 |
|
|
2020
Q1 | $2.13M | Buy |
+19,703
| New | +$2.13M | 1.33% | 32 |
|
|
2016
Q4 | – | Sell |
-11,725
| Closed | -$887K | – | 89 |
|
|
2016
Q3 | $887K | Buy |
11,725
+1,754
| +18% | +$133K | 0.7% | 50 |
|
|
2016
Q2 | $768K | Buy |
+9,971
| New | +$768K | 0.65% | 47 |
|